首页 › 急性淋巴细胞白血病 › 马里兰州 › Baltimore
Baltimore MD 急性淋巴细胞白血病临床试验
9项针对 急性淋巴细胞白血病的研究正在 Baltimore及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- 以及另外 2 项
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
招募中早期 I 期
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Multicenter HomeVENT: Home Values and Experiences Navigation Track
招募中欢迎健康志愿者
- Johns Hopkins University School of Medicine, Baltimore
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- Johns Hopkins, Baltimore
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
招募中观察性研究
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
招募中1/2 期
- Sibley Memorial Hospital, Baltimore
- University of Maryland, Baltimore
- Johns Hopkins Main Center, Baltimore
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
招募中1 期
- University of Maryland, Baltimore
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
招募中1 期
- Johns Hopkins University, Baltimore
其他城市的 急性淋巴细胞白血病试验
- Houston, TX28 项研究
- New York City, NY22 项研究
- Seattle, WA22 项研究
- Baldwin Park, CA21 项研究
- Atlanta, GA20 项研究
- Chicago, IL20 项研究
- Memphis, TN17 项研究
- Philadelphia, PA16 项研究
- Washington, DC16 项研究
- Los Angeles, CA15 项研究
- Boston, MA15 项研究
- Mountain View, CA14 项研究
Baltimore的其他研究
- 非小细胞肺癌60 项研究
- 前列腺癌45 项研究
- 乳腺癌44 项研究
- 肺癌41 项研究
- 癌症（所有类型）36 项研究
- 结直肠癌30 项研究
- 胰腺癌30 项研究
- 转移性癌症26 项研究
- 肥胖症24 项研究
- 膀胱癌24 项研究
- 卵巢癌23 项研究
- 心力衰竭23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。